Jonathan T Md Lord insider trades: Biolase (BIOL) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jonathan reports to the SEC
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 7, 2022 | BIOL | ↓ Sell | 3,537 | $0.75 | $3K | Direct | Dec 8, 2022 (1d) |
| Dec 15, 2021 | BIOL | ↓ Sell | 11,038 | $0.38 | $4K | Direct | Dec 16, 2021 (1d) |
| Nov 16, 2018 | BIOL | ↑ Buy | 10,000 | $1.36 | $14K | Direct | Nov 20, 2018 (4d) |
| Aug 14, 2018 | BIOL | ↑ Buy | 100,000 | $1.31 | $131K | Direct | Aug 14, 2018 (0d) |
| Sep 1, 2016 | DXCM | ↓ Sell | 10,000 | $91.50 | $915K | Direct | Sep 6, 2016 (5d) |
| Aug 12, 2016 | DXCM | ↓ Sell | 10,000 | $90.64 | $906K | Direct | Aug 15, 2016 (3d) |
| Nov 9, 2015 | BIOL | ↑ Buy | 16,310 | $0.75 | $12K | Direct | Nov 12, 2015 (3d) |
| Sep 9, 2015 | DXCM | ↓ Sell | 10,000 | $90.96 | $910K | Direct | Sep 11, 2015 (2d) |
| Nov 11, 2014 | DXCM | ↓ Sell | 18,058 | $53.09 | $959K | Direct | Nov 13, 2014 (2d) |
| Nov 3, 2014 | BIOL | ↑ Buy | 101,163 | $2.39 | $242K | Direct | Nov 5, 2014 (2d) |
| Aug 26, 2014 | DXCM | ↓ Sell | 20,000 | $45.56 | $911K | Direct | Aug 28, 2014 (2d) |
| Mar 13, 2014 | DXCM | ↓ Sell | 36,000 | $45.05 | $1.6M | Direct | Mar 17, 2014 (4d) |
| Feb 25, 2014 | DXCM | ↓ Sell | 64,807 | $45.15 | $2.9M | Direct | Feb 27, 2014 (2d) |
| Jun 28, 2013 | SRCL | ↓ Sell | 6,040 | $110.00 | $664K | Direct | Jul 2, 2013 (4d) |
| Apr 16, 2012 | SRCL | ↓ Sell | 7,000 | $86.84 | $608K | Direct | Apr 17, 2012 (1d) |
| Mar 9, 2012 | SRCL | ↓ Sell | 10,000 | $87.02 | $870K | Direct | Mar 9, 2012 (0d) |
| Dec 20, 2011 | SRCL | ↓ Sell | 3,900 | $78.16 | $305K | Direct | Dec 21, 2011 (1d) |
| May 17, 2010 | DXCM | ↑ Buy | 14,881 | $10.89 | $162K | Direct | May 19, 2010 (2d) |
| May 14, 2010 | DXCM | ↑ Buy | 40,119 | $10.78 | $433K | Direct | May 18, 2010 (4d) |
| Feb 10, 2010 | SRCL | ↑ Buy | 2,000 | $51.15 | $102K | Direct | Feb 11, 2010 (1d) |
| Nov 27, 2007 | HUM | ↓ Sell | 50,000 | $74.57 | $3.7M | Direct | Nov 28, 2007 (1d) |
| May 14, 2007 | HUM | ↓ Sell | 40,000 | $65.03 | $2.6M | Direct | May 15, 2007 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jonathan T Md Lord's insider trades
Jonathan T Md Lord is a director at Biolase (BIOL). Since May 14, 2007, Jonathan has reported 7 open-market purchases worth $1.1M and 15 sales worth $17.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (38 filings), option exercises (19 filings), other transactions (6 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.